A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue diseaese associated interstitial lung disease (RECITAL)

Project Details

StatusFinished
Effective start/end date1/09/1330/06/21

Funding

  • National Institute for Health Research: £62,602.00